HER2 quantification by mass spectrometry compared to IHC or ISH in predicting clinical benefit from anti-HER2 therapy in HER2-positive breast cancer (BC)

Nuciforo, Paolo ; Aura, Claudia ; Thyparambil, Sheeno P ; Vilaro, Marta ; Garrido-Castro, Ana C. ; Peg, Vicente ; Jimenez, Jose ; Hoos, William Arthur ; Burrows, Jon ; Hembrough, Todd A. ; Perez-Garcia, Jose Manuel ; Cortes, Javier ; Scaltriti, Maurizio

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.605-605 [Periódico revisado por pares]

Texto completo disponível